These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Inflammatory bowel disease: genotype-fenotype relationship]. Gómez de la Concha E An R Acad Nac Med (Madr); 2006; 123(2):307-17; discussion 318-20. PubMed ID: 17310638 [TBL] [Abstract][Full Text] [Related]
24. Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. Jess T; Riis L; Jespersgaard C; Hougs L; Andersen PS; Orholm MK; Binder V; Munkholm P Am J Gastroenterol; 2005 Nov; 100(11):2486-92. PubMed ID: 16279904 [TBL] [Abstract][Full Text] [Related]
27. Association of TNF-alpha-857C with inflammatory bowel disease in the Australian population. O'Callaghan NJ; Adams KE; van Heel DA; Cavanaugh JA Scand J Gastroenterol; 2003 May; 38(5):533-4. PubMed ID: 12795465 [TBL] [Abstract][Full Text] [Related]
28. Dysfunctional genomics: toward an integrative biology of disease and health--application to IBDs. Aronow BJ J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E3-4. PubMed ID: 18354326 [No Abstract] [Full Text] [Related]
32. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Thjodleifsson B; Geirsson AJ; Björnsson S; Bjarnason I Arthritis Rheum; 2007 Aug; 56(8):2633-9. PubMed ID: 17665420 [TBL] [Abstract][Full Text] [Related]
33. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Itzkowitz SH Gastroenterol Clin North Am; 2006 Sep; 35(3):553-71. PubMed ID: 16952740 [TBL] [Abstract][Full Text] [Related]
34. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Cantor MJ; Nickerson P; Bernstein CN Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590 [TBL] [Abstract][Full Text] [Related]
35. A new hypothesis on inflammatory bowel diseases. El-Tawil AM Eur Rev Med Pharmacol Sci; 2009; 13(1):66; author reply 67. PubMed ID: 19364088 [No Abstract] [Full Text] [Related]
36. The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease. Russell RK; Drummond HE; Nimmo ER; Anderson N; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J J Pediatr; 2007 Mar; 150(3):268-73. PubMed ID: 17307543 [TBL] [Abstract][Full Text] [Related]
37. Review article: inherited thrombophilia in inflammatory bowel disease. Papa A; Danese S; Grillo A; Gasbarrini G; Gasbarrini A Am J Gastroenterol; 2003 Jun; 98(6):1247-51. PubMed ID: 12818264 [TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease. Seiderer J; Dambacher J; Leistner D; Tillack C; Glas J; Niess JH; Pfennig S; Jürgens M; Müller-Myhsok B; Göke B; Ochsenkühn T; Lohse P; Reinecker HC; Brand S Clin Immunol; 2008 Apr; 127(1):49-55. PubMed ID: 18248772 [TBL] [Abstract][Full Text] [Related]
39. Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease. Sanchez R; Levy E; Seidman E; Amre D; Costea F; Sinnett D Gut; 2006 Dec; 55(12):1820-1. PubMed ID: 17124163 [No Abstract] [Full Text] [Related]
40. Identifying susceptibility to inflammatory bowel diseases: a candidate gene approach, genome-wide association studies, or both? Pavli P; Summers KM J Gastroenterol Hepatol; 2008 Jan; 23(1):6-7. PubMed ID: 18171338 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]